Millions in India to benefit from major price cuts offered by government on anti-cancer drugs
The Indian National Pharmaceutical Pricing Authority (NPPA) recently announced major price cuts (some of them as much as 87%) on 390 different anti-cancer treatment brands, which means that these lifesaving cancer medicines will be available to over 2 million cancer patients in the country at much cheaper rates.
The price cuts are expected to collectively save roughly 8 billion INR ($115 million) in medical bills.
The list of price cuts brings 42 new unscheduled anti-cancer drugs that were previously unaffected by government regulation under a price cap that will offer financial relief to cancer patients across the nation.
The government-regulated price cap is maintained as a means of preventing pharmaceutical companies and wholesalers from profiting off of essential anti-cancer treatments.